Publication date: Jul 15, 2025
To assess heterologous booster (HB) with Janssen Ad26. COV2. S in kidney transplant recipients (KTRs) with low antibody levels after multiple COVID-19 mRNA vaccinations. This multicenter study examined anti-spike protein antibody levels in KTRs with two or more doses of mRNA vaccinations. Enrollment was from April 11, 2022, to September 19, 2023. Kidney transplant recipients with low levels (LL, 0. 4-250 IU/mL) were offered HB with Janssen Ad26. COV2. S vaccine. Those with undetectable levels (UL,
| Concepts | Keywords |
|---|---|
| Kidney | Ad26 |
| Mrna | Antibody |
| September | Assess |
| Vaccination | Boosting |
| Cov2 | |
| Heterologous | |
| Janssen | |
| Kidney | |
| Ktrs | |
| Low | |
| Mrna | |
| Recipients | |
| Transplant | |
| Vaccination | |
| Vaccinations |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | IDO | protein |
Original Article
(Visited 5 times, 1 visits today)